Preparation method of urapidil intermediate 1-(2-methoxyphenyl) piperazine and salt thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 河北广祥制药有限公司
- Publication Date
- 2022-07-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of organic synthesis, in particular to a preparation method of a urapidil intermediate 1-(2-methoxyphenyl)piperazine and a salt thereof. Background technique
[0002] Urapidil is an alpha-adrenergic receptor blocker. As a new type of antihypertensive drug, since it entered the clinic in the 1970s, it has been increasingly used in clinical practice with its unique blood pressure lowering mechanism and significant blood pressure lowering effect. 's approval. Urapidil not only has no significant effect on biochemical indicators such as blood glucose, blood lipids, uric acid, liver function, blood urea nitrogen and creatinine, but also has no significant effect on the patient's heart rate. Patients with gout can take it. At the same time, urapidil also has the functions of increasing high-density lipoprotein, lowering cholesterol, reversing left ventricular hypertrophy and reducing insulin resistance. Therefore, urapidil...